ClinicalTrials.gg
Not yet recruitingNCT07879950Updated Oct 19, 2026

Local Vibration and Ankle Mobilization in Multiple Sclerosis

An interventional study of Local Vibration and Ankle Joint Mobilization in Multiple Sclerosis, sponsored by Gaziantep Islam Science and Technology University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Gaziantep Islam Science and Technology University · Not applicable, Interventional, and Treatment

Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study will investigate the effects of local vibration and ankle joint mobilization on muscle tone, proprioception, and balance in individuals with multiple sclerosis (MS). Participants will be randomly assigned to one of two treatment groups. One group will receive local vibration applied to the gastrocnemius muscle, while the other group will receive ankle joint mobilization. Both interventions will be performed three times per week for six weeks. Muscle tone, ankle joint position sense, and balance will be assessed before and after the intervention. The study aims to determine whether these interventions can improve neuromuscular and balance-related functions in individuals with MS.

02

Conditions studied

  • Multiple Sclerosis

Browse trials for

Keywords

  • Multiple Sclerosis
  • Proprioception
  • Muscle Tone
03

In context

Multiple Sclerosis

3,524 studies on the registry are indexed under Multiple Sclerosis; 668 are open to participants now.

This study's planned enrollment of 60 is above the median of 50 across 2,386 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Gaziantep Islam Science and Technology University is the lead sponsor of 42 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years.
  • Diagnosis of multiple sclerosis confirmed by a neurologist.
  • Expanded Disability Status Scale (EDSS) score ≤6.0.
  • Ability to walk at least 100 meters, with or without an assistive device.
  • No MS relapse within the previous 3 months.
  • Willingness to participate in the study and provision of written informed consent.

Exclusion criteria

Exclusion Criteria:

  • MS relapse within the previous 3 months.
  • Severe cognitive impairment or cognitive problems that may interfere with communication or participation.
  • History of orthopedic surgery involving the lower extremity or presence of a severe orthopedic condition affecting lower-extremity function.
  • Vestibular system disorder or another neurological condition that may affect balance.
  • Any medical condition contraindicating local vibration or manual therapy.
  • Inability to participate regularly throughout the study period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Local Vibration Group

    Participants in this group will receive local mechanical vibration applied to the medial and lateral heads of the gastrocnemius muscle. The intervention will be performed with the participant in the prone position and the ankle in a neutral position. Local vibration will be applied continuously at a frequency of 40 Hz for 3 minutes to each head of the gastrocnemius muscle, for a total duration of 6 minutes per session. The intervention will be administered three times per week for six weeks.

    Behavioral: Local Vibration

  • Active comparator
    Ankle Joint Mobilization Group

    Participants in this group will receive ankle joint mobilization targeting the talocrural joint. Posterior-to-anterior talocrural mobilization will be performed according to the Maitland concept at Grade III. Participants will be positioned supine with the knee slightly flexed and the ankle in a neutral position. Mobilization will be performed for 60 seconds followed by 30 seconds of rest, for 4 sets per session. The intervention will be administered three times per week for six weeks.

    Behavioral: Ankle Joint Mobilization

Interventions

  • BehavioralLocal Vibration

    Local mechanical vibration applied to the medial and lateral heads of the gastrocnemius muscle at 40 Hz, 3 minutes per muscle head, three times per week for six weeks.

  • BehavioralAnkle Joint Mobilization

    Grade III posterior-to-anterior talocrural joint mobilization, 60 seconds per set with 30 seconds rest, 4 sets per session, three times per week for six weeks.

06

What researchers measure

Primary outcomes

  1. Ankle Joint Position Sense Error

    Ankle proprioception will be assessed using a digital goniometer. Participants will reproduce predetermined target ankle joint angles, and the absolute difference in degrees between the target angle and reproduced angle will be recorded as the joint position sense error. Lower error values indicate better proprioceptive accuracy.

    Time frame: Baseline and immediately after the 6-week intervention

Secondary outcomes

  1. Muscle Mechanical Properties

    Muscle mechanical properties of the gastrocnemius and soleus muscles will be assessed using the MyotonPRO device. Muscle tone, stiffness, and elasticity parameters will be recorded.

    Time frame: Baseline and immediately after the 6-week intervention

  2. Trunk Sway

    Static postural control will be assessed using the Gyko inertial measurement unit sensor. Trunk sway parameters obtained from the sensor will be recorded as objective measures of balance and postural control.

    Time frame: Baseline and immediately after the 6-week intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07879950
Lead sponsor
Gaziantep Islam Science and Technology University
Responsible party
Zekiye İpek (Assoc.Prof., Gaziantep Islam Science and Technology University) — Principal investigator
First posted
Oct 19, 2026
Start date
Dec 15, 2026 (estimated)
Primary completion
May 15, 2027 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Oct 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion